NCT05479396Completed
The Predictive Capacity of Peripheral Muscle Function on Quality of Life Impairment at 1 Year in Subjects With Obesity
Study of the Predictive Capacity of Peripheral Muscle Function on Quality of Life Impairment at 1 Year in Subjects With Obesity. A Cohort Study.
Source: ClinicalTrials.gov · Last updated 1 Jul 2024
Brief summary (registry, in English)
The assessment of health status and physical function is fundamental in patients with obesity, as they play an important role among the various factors influencing quality of life in this population. Several studies have shown an association between high BMI values and a significant deterioration in quality of life, especially in women. Excess body fat in obese patients appears to be responsible for impaired muscle function. This causal link is probably linked to dysfunctions in adipose tissue, leading to a decrease in the expression of proteins responsible for muscle contraction. The recent literature highlights an alteration in quality of life, particularly in obese and elderly subjects, for which changes in muscle function are partly responsible. Changes in muscle function can be assessed by simple, rapid and non-invasive tools. These changes in the obese patient could be predictive of reduced quality of life. To our knowledge, no study has evaluated the predictive capacity of muscle alteration assessed by ultrasound on the medium-term quality of life of obese patients. The main objective of this study is to evaluate the predictive capacity of structural alteration of the quadriceps on the decrease in quality of life at 1 year in patients with obesity. The secondary objectives are to assess the association between : * Grip strength and quality of life at 1 year; * Quadriceps muscle strength and quality of life at 1 year; * Ultrasound measurements of the quadriceps and quality of life at 1 year; * Ultrasound measurements of the quadriceps and autonomy at 1 year; * Grip strength and autonomy at 1 year. This is a prospective, monocenter, observationnal and cohort study. All outpatients for nutrition assessment will be included.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 90 (actual)
- First submitted
- 15 Jul 2022
- Start date
- 22 Apr 2022
- Primary completion date
- 10 Jul 2023
- Lead sponsor
- Hopital Forcilles
- Diseases
- Obesity
- NCT number
- NCT05479396
What you commit to
- Study type: Observational
- Participants enrolled: 90
- From 22 Apr 2022 to the primary completion date, 10 Jul 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patient's refusal to participate in the study ;
- Known pregnancy ;
- Patient whose state of consciousness is not compatible with obtaining consent ;
- Person subject to a legal protection measure ;
- Patient under guardianship or curatorship.
Who the study is looking for
- Outpatients assessment Nutrition
- Obese patients (BMI \> 30);
- Patient at least 18 years old at the time of inclusion;
- Affiliation with a social security scheme or beneficiary of such a scheme ;
- Oral, free, informed and express consent of the patient.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hôpital Forcilles Coordinator of this site? Confirm its status | Férolles-Attilly | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.